Effects of Prolonged Exposure in Vitro to Interferon-γ and Tumour Necrosis Factor-α on Nitric Oxide and Insulin Production of Rat Pancreatic Islets

References

• Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
   PubMed Web of Science ®Google Scholar
• Nakhooda A. F., Like A. A., Chappel C. I., Wei C. N., Marliss E. B. The spontaneously diabetic Wistar rat (the “BB” rat): studies prior to and during development of the overt syndrome. Diabetologia. 1978; 14: 199–207
   PubMed Web of Science ®Google Scholar
• Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 1980; 29: 1–13
   PubMedGoogle Scholar
• Nerup J., Mandrup-Poulsen T., Mølvig J., et al. Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care 1988; 11(Suppl. 1)16–23
   PubMedGoogle Scholar
• Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune and endocrine diseases. Autoimmunity 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Nerup J., et al. Affinity-purified human interleukin 1 is cytotoxic to islet cells of Langerhans. Diabetologia. 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Mandrup-Poulsen T., Nerup J., et al. Cytotoxicity of human p17 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Sandler S., Andersson A., Hellerström C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Sandler S., Bendtzen K., Borg L. A. H., Eizirik D. L., Strandell E., Welsh N. Studies on the mechanism causing inhibition of insulin secretion in rat pancreatic islets exposed to interleukin-1β indicate a pertubation in the mitochondrial function. Endocrinology 1989; 124: 1492–1501
   PubMed Web of Science ®Google Scholar
• Southern C., Schulster D., Green I. C. Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990; 276: 42–44
   PubMed Web of Science ®Google Scholar
• Welsh N., Eizirik D. L., Bendtzen K., Sandler S. Interleukin-1β-induced nitric oxide production in isolated rat pancratic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167–3173
   PubMed Web of Science ®Google Scholar
• Corbett J. A., Lancaster J. R., Jr, Sweetland M. A., McDaniel M. L. Interleukin-1 β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1β-induced inhibition of insulin secretion. J. Biol. Chem. 1991; 266: 21 351–21 354
   Google Scholar
• Corbett J. A., Wang J. L., Hughes J. H., et al. Nitric oxide and cyclic GMP formation induced by interleukin 1β in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem. J. 1992; 287: 229–235
   PubMed Web of Science ®Google Scholar
• Sandler S., Bendtzen K., Eizirik D. L., Strandell E., Welsh M., Welsh N. Metabolism and β-cell function of rat pancreatic islets exposed to human interleukin-1β in the presence of a high glucose concentration. Immunol. Lett. 1990; 26: 245–252
   PubMed Web of Science ®Google Scholar
• Jiang Z., Woda B. A. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J. Immunol. 1992; 146: 2990–2994
   Google Scholar
• Welsh M., Welsh N., Bendtzen K., Mares J., Strandell E., Öberg C., Sandler S. Comparison of mRNA contents of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia. 1995; 38: 153–160
   PubMed Web of Science ®Google Scholar
• Fomsgaard A., Worsaae H., Bendtzen K. Detection of tumour necrosis factor from lipopolysaccaride-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand. J. Immunol. 1988; 27: 143–147
   PubMed Web of Science ®Google Scholar
• Hinegardner R. T. An improved fluorometric assay for DNA. Anal. Biochem. 1971; 39: 197–201
   PubMed Web of Science ®Google Scholar
• Heding L. G. Determination of total serum insulin (IRI) in insulin-treated patients. Diabetologia. 1972; 8: 260–266
   PubMed Web of Science ®Google Scholar
• Rrebs H. A., Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seylers. Z. Physiol. Chem. 1932; 210: 33–36
   Google Scholar
• Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite and [15]nitrate in biological fluids. Anal. Biochem. 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Andersson A., Sandler S. Viability test of cryopreserved endocrine pancreatic cells. Cryobiology 1982; 20: 161–168
   Google Scholar
• Eizirik D. L., Cagliero E., Björklund A., Welsh N. Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett. 1992; 308: 249–252
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Björklund A., Welsh N. Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS. Lett. 1993; 317: 62–66
   PubMedGoogle Scholar
• Eizirik D. L., Sandler S., Palmer J. P. Repair of pancreatic β-cells. A relevant phenomenon in early IDDM?. Diabetes 1993; 42: 1383–1391
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Sandler S., Welsh N., et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 1994; 93: 1968–1974
   PubMed Web of Science ®Google Scholar
• Welsh N., Eizirik D. L., Sandler S. Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: Don't take NO for an answer. Autoimmunity 1994; 18: 285–290
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T., Bendtzen K., Dinarello C. A., Nerup J. Human tumor necrosis factor potentiates interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J. Immunol. 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Pukel C., Baquerizo H., Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin and interleukin 1. Diabetes 1988; 37: 133–136
   PubMed Web of Science ®Google Scholar
• Rabinovitch A., Baquerizo H., Pukel C., Sumoski W. Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects in islet β-cells. Reg. Immunol. 1989; 2: 77–82
   Google Scholar
• Cetkovic-Cvrlje M., Eizirik D. L. TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 1994; 6: 399–406
   PubMed Web of Science ®Google Scholar
• Shimizu F., Shimizu M., Kamiyama K. Inhibitory effect of interferon on the production of insulin. Endocrinology 1985; 117: 2081–2084
   Google Scholar
• Campbell I. L., Oxbrow L., Harrison L. C. Interferon-γ: pleiotropic effects on a rat pancreatic beta cell line. Mol. Cell. Endocrinol. 1987; 52: 161–167
   PubMed Web of Science ®Google Scholar
• Sjöholm Å. Cytokines inhibit proliferation and insulin secretionby clonal rat insulinoma cells (RINm5F) non-synergistically and in a pertussis toxin-insensitive manner. Immunol. Lett. 1989; 30: 81–86
   Google Scholar
• Jancic D., Asfari M. Effects of cytokines on rat insulinoma INS-1 cells. J. Endocrinol. 1992; 132: 67–76
   Google Scholar
• Rabinovitch A., Sumoski W., Rajotte R. V., Warnock G. L. Cytotoxic effects of cytokines in human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 1990; 71: 152–156
   PubMed Web of Science ®Google Scholar
• Soldevilla G., Buscema M., Doshi M., et al. Cytotoxic effect of IFN-γ plus TNF-α on human islet cells. J. Autoimmunity 1991; 4: 291–306
   Google Scholar
• Kawahara D. J., Kenney J. S. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti interleukin-1 (IL-1) influences on direct and indirect IL-1 mediated islet effects. Cytokine 1991; 3: 117–124
   Google Scholar
• Corbett J. A., Sweetland M. A., Wang J. L., Lancaster J. R., Jr, McDaniel M. L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 1993; 90: 1731–1735
   PubMed Web of Science ®Google Scholar
• Palmer J. P., Helqvist S., Spinas G. A., et al. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989; 38: 1211–1216
   PubMed Web of Science ®Google Scholar
• Southern C., Schulster D., Green I. C. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1. Biochem. J. 1990; 272: 243–245
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Iscaro A., Harrison L. C. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J. Immunol. 1988; 141: 2325–2329
   PubMed Web of Science ®Google Scholar